2026/1/12 11:37:19
2651
| 日期 | 活動主題 | 主講者 | 照片 |
| 2025/01/23 | Mounjaro藥物介紹 | MSL 學術經理 陳映蓉 |
 |
| 2025/02/27 | Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure | 一般外科 葉佳璋醫師 |
 |
| 2025/03/27 | Intermittent fasting triggers interorgan communication to suppress hair follicle regeneration |
一般外科 張家瑜醫師 |
 |
| 2025/04/24 | Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes |
一般外科 陳智翔醫師 |
 |
| 2025/05/29 | Tirzepatide as Compared with Semaglutide for the Treatment of Obesity | 一般外科 蔡筠辰醫師 |
 |
| 2025/06/26 | Wegovy全球首創一週一次GLP-1RA於長期體重管理 | 台灣諾和諾德 李紓婷 |
 |
| 2025/07/31 | Preoperative risk factors for suboptimal initial clinical response or weight regain in patients undergoing bariatric surgery, a retrospective cohort study from ahigh‑volume center |
一般外科賴彥臻醫師 |
 |
| 2025/08/28 | Mounjaro-Integrating Dual Incretin Therapy into Obesity Care: Clinical Perspectives from SURMOUNT | 鄭由承醫師 |
 |
| 2025/09/25 | 減重營養補給 | 邱玉梅 |
 |
| 2025/10/30 | Glucagon-like peptide-1 receptor agonists compared with bariatric metabolic surgery and the risk of obesity-related cancer: an observational, retrospective cohort study | 陳威宇醫師 |
 |
| 2025/11/27 | Body Mass Index and Postsurgical Outcomes in Older Adults | 林瑋麗醫師 |
 |
| 2025/11/29 | 享瘦人生-窈窕俱樂部 |
 |
|
| 2025/12/18 | World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults |
詹孟蓁醫師 |
 |
分享
首長信箱
分享
